<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Lamivudin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:02 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="filelist-307.xml.html" tppabs="http://www.vietstarse.com/duocthu/Documents/Lamivudin_files/filelist.xml">
<link rel=Edit-Time-Data href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Lamivudin_files/editdata.mso  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Lamivudin_files/editdata.mso'" tppabs="http://www.vietstarse.com/duocthu/Documents/Lamivudin_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title>LAMIVUDIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VS35</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>4</o:TotalTime>
  <o:Created>2006-08-08T14:07:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:26:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1283</o:Words>
  <o:Characters>7319</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>60</o:Lines>
  <o:Paragraphs>17</o:Paragraphs>
  <o:CharactersWithSpaces>8585</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	page-break-before:always;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:12.0pt;
	font-family:Tahoma;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>LAMIVUDIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tên
chung qu&#7889;c t&#7871;</span></b><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>: Lamivudine.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Mã ATC: </span></b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>J05A
F05.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i
thu&#7889;c</span></b><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>: Thu&#7889;c kháng retrovirus.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lamivudin,
u&#7889;ng</span></i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>: Dung d&#7883;ch 10 mg/ml. Viên bao phim 150 mg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lamivudin
k&#7871;t h&#7907;p, u&#7889;ng</span></i><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>: Viên bao phim ch&#7913;a 150 mg
lamivudin và 300 mg zidovudin.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lamivudin
là 1 thu&#7889;c t&#7893;ng h&#7907;p kháng retrovirus, thu&#7897;c nhóm
dideoxynucleosid &#7913;c ch&#7871; enzym phiên mã ng&#432;&#7907;c c&#7911;a
virus. Ð&#7875; có tác d&#7909;ng lamivudin ph&#7843;i &#273;&#432;&#7907;c
enzym t&#7871; bào phosphoryl hóa và bi&#7871;n &#273;&#7893;i thành m&#7897;t
ch&#7845;t chuy&#7875;n hóa có ho&#7841;t tính, ch&#7845;t chuy&#7875;n hóa 5 -
triphosphat. Ch&#7845;t chuy&#7875;n hóa này có c&#7845;u trúc t&#432;&#417;ng
t&#7921; deoxycytidin triphosphat là c&#417; ch&#7845;t t&#7921; nhiên cho
enzym phiên mã ng&#432;&#7907;c. Thu&#7889;c có ho&#7841;t tính c&#7841;nh
tranh v&#7899;i deoxycytidin triphosphat t&#7921; nhiên &#273;&#7875; h&#7907;p
nh&#7845;t vào DNA c&#7911;a virus b&#7903;i enzym phiên mã ng&#432;&#7907;c,
gây k&#7871;t thúc s&#7899;m t&#7893;ng h&#7907;p DNA c&#7911;a virus.
Lamivudin có &#273;&#7897;c tính r&#7845;t th&#7845;p &#273;&#7889;i v&#7899;i
t&#7871; bào.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Lamivudin
có ho&#7841;t tính kìm virus HIV typ 1 và 2 (HIV - 1, HIV - 2), và c&#361;ng có
tác d&#7909;ng &#7913;c ch&#7871; virus viêm gan B &#7903; ng&#432;&#7901;i b&#7879;nh
m&#7841;n tính. Tuy &#273;&#432;&#7907;c dung n&#7841;p t&#7889;t, nh&#432;ng
không &#273;&#432;&#7907;c dùng lamivudin &#273;&#417;n &#273;&#7897;c, vì d&#7877;
sinh kháng thu&#7889;c. S&#7921; kháng này do &#273;&#7897;t bi&#7871;n v&#7873;
enzym phiên mã ng&#432;&#7907;c, làm gi&#7843;m tính nh&#7841;y c&#7843;m
h&#417;n 100 l&#7847;n và làm m&#7845;t tác d&#7909;ng kháng virus trên
ng&#432;&#7901;i b&#7879;nh. Li&#7879;u pháp ph&#7889;i h&#7907;p lamivudin và
zidovudin &#7903; ng&#432;&#7901;i b&#7879;nh ch&#432;a &#273;&#432;&#7907;c
&#273;i&#7873;u tr&#7883; tr&#432;&#7899;c &#273;ây, làm gi&#7843;m kho&#7843;ng
10 l&#7847;n m&#7853;t &#273;&#7897; virus trong huy&#7871;t t&#432;&#417;ng,
tác d&#7909;ng kéo dài h&#417;n 1 n&#259;m, m&#7863;c dù có s&#7921; &#273;&#7897;t
bi&#7871;n c&#7911;a enzym phiên mã ng&#432;&#7907;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cách
dùng thu&#7889;c kháng retrovirus: </span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Trong li&#7879;u pháp kháng
retrovirus, thu&#7889;c ch&#7885;n l&#7885;c là nh&#7919;ng thu&#7889;c
t&#432;&#417;ng t&#7921; nucleosid. Hi&#7879;n nay ch&#432;a bi&#7871;t rõ lúc
nào là th&#7901;i &#273;i&#7875;m t&#7889;t nh&#7845;t &#273;&#7875; b&#7855;t
&#273;&#7847;u &#273;i&#7873;u tr&#7883; v&#7899;i thu&#7889;c kháng
retrovirus. Li&#7879;u pháp kháng retrovirus c&#361;ng làm t&#259;ng th&#7901;i
gian s&#7889;ng sót &#7903; ng&#432;&#7901;i b&#7879;nh có s&#7889; l&#432;&#7907;ng
t&#7871; bào CD4 d&#432;&#7899;i 500 trong 1 mm<sup>3</sup>. Li&#7879;u pháp
này c&#361;ng có th&#7875; dùng cho nh&#7919;ng ng&#432;&#7901;i b&#7879;nh có
m&#7853;t &#273;&#7897; HIV trên 30.000/ml huy&#7871;t t&#432;&#417;ng, không
ph&#7909; thu&#7897;c vào s&#7889; l&#432;&#7907;ng t&#7871; bào CD4, vì m&#7853;t
&#273;&#7897; HIV là m&#7897;t y&#7871;u t&#7889; tiên l&#432;&#7907;ng s&#7921;
ti&#7871;n tri&#7875;n c&#7911;a b&#7879;nh. M&#7853;t &#273;&#7897; virus cao
h&#417;n d&#7851;n &#273;&#7871;n gi&#7843;m t&#7871; bào CD4 nhanh h&#417;n. M&#7909;c
tiêu &#273;i&#7873;u tr&#7883; là &#273;&#7841;t m&#7853;t &#273;&#7897; HIV &#7903;
m&#7913;c không th&#7875; phát hi&#7879;n &#273;&#432;&#7907;c. Li&#7879;u pháp
chu&#7849;n hi&#7879;n nay g&#7891;m 2 thu&#7889;c t&#432;&#417;ng t&#7921;
nucleosid kháng retrovirus, cùng v&#7899;i m&#7897;t thu&#7889;c &#7913;c ch&#7871;
protease. S&#7921; tuân th&#7911; &#273;i&#7873;u tr&#7883; có tính quy&#7871;t
&#273;&#7883;nh cho hi&#7879;u l&#7921;c duy trì c&#7911;a thu&#7889;c. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
b&#7879;nh &#273;i&#7873;u tr&#7883; không có k&#7871;t qu&#7843; (t&#259;ng g&#7845;p
3 l&#7847;n m&#7853;t &#273;&#7897; virus, ho&#7863;c gi&#7843;m s&#7889;
l&#432;&#7907;ng t&#7871; bào CD4, ho&#7863;c ti&#7871;n tri&#7875;n thành b&#7879;nh
AIDS) ph&#7843;i chuy&#7875;n sang dùng m&#7897;t k&#7871;t h&#7907;p thu&#7889;c
kháng retrovirus khác. Ph&#7843;i l&#7921;a ch&#7885;n k&#7871;t h&#7907;p thu&#7889;c
m&#7899;i sao cho nguy c&#417; kháng chéo v&#7899;i nh&#7919;ng thu&#7889;c
&#273;ã dùng là t&#7889;i thi&#7875;u. Khi li&#7879;u pháp c&#361; không có tác
d&#7909;ng c&#7847;n cho thêm thu&#7889;c m&#7899;i, nguyên t&#7855;c là cho
thêm không ch&#7881; m&#7897;t thu&#7889;c, mà k&#7871;t h&#7907;p 2 thu&#7889;c
m&#7899;i. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Xem xét
nguy c&#417; c&#7911;a t&#432;&#417;ng tác thu&#7889;c khi &#273;i&#7873;u tr&#7883;
v&#7899;i các thu&#7889;c kháng retrovirus.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
&#273;&#7897;ng h&#7885;c<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Sau khi
u&#7889;ng, lamivudin h&#7845;p thu nhanh v&#7899;i sinh kh&#7843; d&#7909;ng
kho&#7843;ng 80%. Sau khi tiêm t&#297;nh m&#7841;ch, th&#7875; tích phân b&#7889;
là 1,3 ± 0,4 lít/kg. T&#7927; l&#7879; g&#7855;n v&#7899;i protein huy&#7871;t
t&#432;&#417;ng th&#7845;p (&lt; 36%). 5 - 6% thu&#7889;c &#273;&#432;&#7907;c
chuy&#7875;n hóa thành ch&#7845;t trans - sulfoxyd. N&#7917;a &#273;&#7901;i th&#7843;i
tr&#7915; trong huy&#7871;t t&#432;&#417;ng trung bình là 2,5 gi&#7901; và kho&#7843;ng
70% c&#7911;a li&#7873;u &#273;&#432;&#7907;c th&#7843;i tr&#7915; không thay
&#273;&#7893;i trong n&#432;&#7899;c ti&#7875;u. N&#7917;a &#273;&#7901;i c&#7911;a
lamivudin triphosphat trong t&#7871; bào kéo dài, trung bình trên 10 gi&#7901;
trong t&#7871; bào lympho &#7903; máu ngo&#7841;i biên. Ð&#7897; thanh th&#7843;i
toàn b&#7897; là 0,37 ± 0,05 lít/gi&#7901;/kg.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Nhi&#7877;m
virus HIV ph&#7843;i dùng k&#7871;t h&#7907;p v&#7899;i ít nh&#7845;t m&#7897;t
thu&#7889;c dideoxynucleosid &#7913;c ch&#7871; enzym phiên mã ng&#432;&#7907;c
khác, th&#432;&#7901;ng k&#7871;t h&#7907;p v&#7899;i zidovudin ho&#7863;c
stavudin.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá m&#7851;n
v&#7899;i b&#7845;t c&#7913; thành ph&#7847;n nào c&#7911;a thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7879;nh
th&#7853;n n&#7863;ng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>&#7903;
tr&#7867; em có ti&#7873;n s&#7917; viêm t&#7909;y ho&#7863;c có y&#7871;u t&#7889;
nguy c&#417; phát tri&#7875;n viêm t&#7909;y, khi dùng k&#7871;t h&#7907;p
lamivudin và zidovudin ph&#7843;i theo dõi ch&#7863;t ch&#7869;. Khi có nh&#7919;ng
d&#7845;u hi&#7879;u lâm sàng, ho&#7863;c k&#7871;t qu&#7843; xét nghi&#7879;m
khác th&#432;&#7901;ng nghi là viêm t&#7909;y, c&#7847;n ph&#7843;i ng&#7915;ng
thu&#7889;c ngay. Ch&#7881; d&#7851;n cho ng&#432;&#7901;i thân ho&#7863;c
ng&#432;&#7901;i trông nom tr&#7867; em nhi&#7877;m HIV v&#7873; nh&#7919;ng d&#7845;u
hi&#7879;u và tri&#7879;u ch&#7913;ng c&#7911;a viêm t&#7909;y. &#7903;
ng&#432;&#7901;i b&#7883; suy ch&#7913;c n&#259;ng th&#7853;n, tr&#7867;
d&#432;&#7899;i 12 tu&#7893;i và thi&#7871;u niên cân n&#7863;ng d&#432;&#7899;i
50 kg, không dùng ch&#7871; ph&#7849;m k&#7871;t h&#7907;p c&#7889; &#273;&#7883;nh
ch&#7913;a lamivudin và zidovudin, vì không th&#7875; hi&#7879;u ch&#7881;nh
riêng t&#7915;ng thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Báo cho
ng&#432;&#7901;i b&#7879;nh bi&#7871;t là lamivudin không ch&#7919;a kh&#7887;i
nhi&#7877;m HIV, h&#7885; v&#7851;n ti&#7871;p t&#7909;c mang b&#7879;nh do nhi&#7877;m
HIV, k&#7875; c&#7843; nhi&#7877;m khu&#7849;n c&#417; h&#7897;i. Ng&#432;&#7901;i
b&#7879;nh v&#7851;n ph&#7843;i &#273;&#432;&#7907;c theo dõi và ch&#259;m sóc
liên t&#7909;c. Ch&#7881; d&#7851;n cho ng&#432;&#7901;i b&#7879;nh bi&#7871;t
là lamivudin không làm gi&#7843;m nguy c&#417; lây truy&#7873;n HIV, và h&#7885;
ph&#7843;i dùng bao cao su &#273;&#7875; b&#7843;o v&#7879; b&#7841;n tình. <o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Có th&#7875;
dùng lamivudin cho ng&#432;&#7901;i mang thai, &#273;&#7863;c bi&#7879;t khi có
c&#417; may b&#7843;o v&#7879; kh&#7887;i lây nhi&#7877;m sang thai nhi.
Tr&#432;&#7901;ng h&#7907;p dùng lamivudin k&#7871;t h&#7907;p u&#7889;ng (viên
lamivudin và zidovudin), tránh dùng cho ng&#432;&#7901;i mang thai.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7863;c
dù không bi&#7871;t lamivudin có bài ti&#7871;t trong s&#7919;a ng&#432;&#7901;i
hay không, có kh&#7843; n&#259;ng x&#7843;y ra nh&#7919;ng tác d&#7909;ng không
mong mu&#7889;n do lamivudin &#7903; tr&#7867; nh&#7887; bú s&#7919;a. C&#361;ng
có nguy c&#417; cao lây nhi&#7877;m HIV do bú s&#7919;a. Ch&#7881; d&#7851;n
cho ng&#432;&#7901;i m&#7865; b&#7883; nhi&#7877;m HIV không nên cho con bú.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác
d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#432;&#7901;ng
g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoBodyText2 align=left style='margin-left:0in;text-align:left;
text-indent:0in;line-height:150%'><span style='mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Nh&#7913;c
&#273;&#7847;u, m&#7845;t ng&#7911;, khó ch&#7883;u, m&#7879;t m&#7887;i,
&#273;au, chóng m&#7863;t, tr&#7847;m c&#7843;m, s&#7889;t, rét run.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Bu&#7891;n nôn, nôn, &#7881;a ch&#7843;y, chán &#259;n, &#273;au b&#7909;ng,
khó tiêu, t&#259;ng amylase.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7847;n
kinh - c&#417; và x&#432;&#417;ng: B&#7879;nh dây th&#7847;n kinh ngo&#7841;i
biên, d&#7883; c&#7843;m, &#273;au c&#417;, &#273;au kh&#7899;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Hô h&#7845;p:
D&#7845;u hi&#7879;u và tri&#7879;u ch&#7913;ng &#7903; m&#361;i, ho.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Da: Ban.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
h&#7885;c: Gi&#7843;m b&#7841;ch c&#7847;u trung tính, thi&#7871;u máu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Gan:
T&#259;ng AST, ALT.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ít g&#7863;p,
1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tiêu
hóa: Viêm t&#7909;y.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Huy&#7871;t
h&#7885;c: Gi&#7843;m ti&#7875;u c&#7847;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Gan:
T&#259;ng bilirubin huy&#7871;t.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng
d&#7851;n cách x&#7917; trí ADR<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ph&#7843;i
ng&#7915;ng lamivudin ngay n&#7871;u có nh&#7919;ng d&#7845;u hi&#7879;u lâm
sàng, tri&#7879;u ch&#7913;ng, ho&#7863;c k&#7871;t qu&#7843; xét nghi&#7879;m
cho th&#7845;y có th&#7875; x&#7843;y ra viêm t&#7909;y.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Bao gi&#7901;
c&#361;ng ph&#7843;i dùng lamivudin k&#7871;t h&#7907;p v&#7899;i ít nh&#7845;t
m&#7897;t thu&#7889;c kháng retrovirus, th&#432;&#7901;ng k&#7871;t h&#7907;p v&#7899;i
zidovudin ho&#7863;c stavudin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cách
dùng: </span></i><span style='mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana'>Lamivudin và ch&#7871; ph&#7849;m k&#7871;t h&#7907;p c&#7889;
&#273;&#7883;nh ch&#7913;a lamivudin và zidovudin &#273;&#432;&#7907;c dùng u&#7889;ng,
không c&#7847;n l&#432;u ý &#273;&#7871;n các b&#7919;a &#259;n, V&#7899;i
ng&#432;&#7901;i b&#7879;nh &#273;i&#7873;u tr&#7883; b&#7857;ng thu&#7889;c
kháng retrovirus, ph&#7843;i &#273;ánh giá liên t&#7909;c &#273;&#7897;c tính
và ti&#7871;n tri&#7875;n c&#7911;a b&#7879;nh, và th&#7921;c hi&#7879;n nh&#7919;ng
thay &#273;&#7893;i trong cách dùng thu&#7889;c khi có ch&#7881; &#273;&#7883;nh.Th&#7901;i
gian có hi&#7879;u qu&#7843; c&#7911;a m&#7897;t k&#7871;t h&#7907;p thu&#7889;c
kháng retrovirus có th&#7875; b&#7883; h&#7841;n ch&#7871;, và c&#7847;n ph&#7843;i
xác &#273;&#7883;nh, &#273;&#7883;nh k&#7923; &#273;&#7873;u &#273;&#7863;n, m&#7913;c
RNA c&#7911;a HIV - 1 và s&#7889; l&#432;&#7907;ng t&#7871; bào TCD4<sup>+</sup>,
&#273;&#7875; xác &#273;&#7883;nh nguy c&#417; ti&#7871;n tri&#7875;n c&#7911;a
b&#7879;nh và &#273;&#7875; quy&#7871;t &#273;&#7883;nh thay &#273;&#7893;i ch&#7871;
&#273;&#7897; dùng thu&#7889;c kháng retrovirus n&#7871;u c&#7847;n. Duy trì li&#7873;u
l&#432;&#7907;ng t&#7889;i &#432;u có tính quy&#7871;t &#273;&#7883;nh &#273;&#7875;
tránh ho&#7841;t tính kháng retrovirus d&#432;&#7899;i m&#7913;c t&#7889;i
&#432;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng</span></i><span style='mso-bidi-font-size:14.0pt;line-height:
150%;font-family:Verdana'>: Li&#7873;u l&#432;&#7907;ng thu&#7889;c kháng
retrovirus d&#7921;a trên th&#7875; tr&#7885;ng và tu&#7893;i c&#7911;a
ng&#432;&#7901;i b&#7879;nh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ng&#432;&#7901;i
l&#7899;n và thi&#7871;u niên 16 tu&#7893;i tr&#7903; lên</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: 150 mg
lamivudin và 300 mg zidovudin cách 12 gi&#7901; m&#7897;t l&#7847;n cho
ng&#432;&#7901;i cân n&#7863;ng 50 kg tr&#7903; lên, 2 mg lamivudin/kg th&#7875;
tr&#7885;ng và 4 mg zidovudin/kg th&#7875; tr&#7885;ng, cách 12 gi&#7901; m&#7897;t
l&#7847;n cho ng&#432;&#7901;i cân n&#7863;ng d&#432;&#7899;i 50 kg.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thi&#7871;u
niên 12 &#273;&#7871;n 16 tu&#7893;i</span></i><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>: 150 mg lamivudin và 300 mg
zidovudin cách 12 gi&#7901; m&#7897;t l&#7847;n cho ng&#432;&#7901;i cân n&#7863;ng
50 kg tr&#7903; lên; không có t&#432; li&#7879;u &#273;&#7847;y &#273;&#7911;
&#273;&#7875; ch&#7881; d&#7851;n li&#7873;u dùng cho thi&#7871;u niên d&#432;&#7899;i
50 kg th&#7875; tr&#7885;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tr&#7867;
em t&#7915; 3 tháng &#273;&#7871;n 12 tu&#7893;i</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>: 4 mg
lamivudin/kg, cách 12 gi&#7901; m&#7897;t l&#7847;n, t&#7889;i &#273;a t&#7899;i
li&#7873;u 300 mg lamivudin m&#7895;i ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng cho ng&#432;&#7901;i suy gi&#7843;m ch&#7913;c n&#259;ng th&#7853;n:</span></i><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Ph&#7843;i
gi&#7843;m li&#7873;u &#7903; ng&#432;&#7901;i b&#7879;nh 16 tu&#7893;i tr&#7903;
lên có &#273;&#7897; thanh th&#7843;i creatinin gi&#7843;m. &#7842;nh h&#432;&#7903;ng
c&#7911;a suy th&#7853;n trên th&#7843;i tr&#7915; lamivudin &#7903; tr&#7867;
em và thi&#7871;u niên d&#432;&#7899;i 16 tu&#7893;i ch&#432;a &#273;&#432;&#7907;c
bi&#7871;t rõ, nên hi&#7879;n nay không có ch&#7881; d&#7851;n v&#7873; li&#7873;u
cho ng&#432;&#7901;i b&#7879;nh &#7903; nhóm tu&#7893;i này có &#273;&#7897;
thanh th&#7843;i creatinin gi&#7843;m.<o:p></o:p></span></p>

<span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;
font-family:Verdana;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Tahoma;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7843;ng
&#273;i&#7873;u ch&#7881;nh li&#7873;u dùng theo &#273;&#7897; thanh th&#7843;i
creatinin<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:429pt;
 height:116.25pt'>
 <v:imagedata src="Lamivudin_files/image001.png" o:title="untitled"/>
</v:shape><![endif]--><![if !vml]><img width=572 height=155
src="image002-25.html" tppabs="http://www.vietstarse.com/duocthu/Documents/Lamivudin_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]><o:p></o:p></span></p>

<p class=MsoCaption align=left style='margin-top:0in;text-align:left;
line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:14.0pt;
line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>N&#7891;ng
&#273;&#7897; zidovudin trong huy&#7871;t t&#432;&#417;ng t&#259;ng lên
&#273;áng k&#7875; (kho&#7843;ng 39%) khi dùng k&#7871;t h&#7907;p v&#7899;i
lamivudin. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Trimethoprim/sulfamethoxazol
làm t&#259;ng sinh kh&#7843; d&#7909;ng c&#7911;a lamivudin (44%) th&#7875; hi&#7879;n
qua tr&#7883; s&#7889; &#273;o di&#7879;n tích d&#432;&#7899;i &#273;&#432;&#7901;ng
cong n&#7891;ng &#273;&#7897; - th&#7901;i gian (AUC), và làm gi&#7843;m &#273;&#7897;
thanh th&#7843;i qua th&#7853;n (30%). <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>M&#7863;c
dù AUC không b&#7883; &#7843;nh h&#432;&#7903;ng nhi&#7873;u, s&#7921; h&#7845;p
thu lamivudin b&#7883; ch&#7853;m l&#7841;i và n&#7891;ng &#273;&#7897; &#273;&#7881;nh
huy&#7871;t t&#432;&#417;ng th&#7845;p h&#417;n 40% khi cho ng&#432;&#7901;i b&#7879;nh
u&#7889;ng thu&#7889;c lúc no so v&#7899;i khi u&#7889;ng thu&#7889;c lúc
&#273;ói.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>B&#7843;o
qu&#7843;n viên nén lamivudin &#7903; 2 - 30<sup>o</sup>C trong l&#7885; &#273;&#7853;y
kín, và dung d&#7883;ch lamivudin u&#7889;ng &#7903; 2 - 25<sup>o</sup>C trong
l&#7885; &#273;&#7853;y kín. Viên lamivudin k&#7871;t h&#7907;p u&#7889;ng
(lamivudin, zidovudin), tránh &#7849;m và tránh ánh sáng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá
li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Có r&#7845;t
ít thông tin v&#7873; quá li&#7873;u, m&#7863;c dù khi quá li&#7873;u, không th&#7845;y
có d&#7845;u hi&#7879;u lâm sàng ho&#7863;c tri&#7879;u ch&#7913;ng, m&#7863;t
khác xét nghi&#7879;m máu v&#7851;n bình th&#432;&#7901;ng. Không có thu&#7889;c
gi&#7843;i &#273;&#7897;c. Không bi&#7871;t rõ lamivudin có b&#7883; lo&#7841;i
tr&#7915; b&#7857;ng th&#7849;m tách màng b&#7909;ng ho&#7863;c th&#7849;m tách
máu hay không.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thu&#7889;c
&#273;&#7897;c b&#7843;ng A.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thành ph&#7849;m
gi&#7843;m &#273;&#7897;c: Thu&#7889;c viên có hàm l&#432;&#7907;ng t&#7889;i
&#273;a là 100 mg, dung d&#7883;ch u&#7889;ng có n&#7891;ng &#273;&#7897; t&#7889;i
&#273;a là 0,1%.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Lamivudin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:03 GMT -->
</html>
